Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Roche has dissolved an antibiotics pact with the Swiss biotech firm Polyphor. The companies joined forces in 2013 to develop POL7080, a macrocycle antibiotic currently in Phase II tests to treat hospital-acquired bacterial infections caused by Pseudomonas aeruginosa. Polyphor says it plans to continue the trials. The partnership was one of the first established by Roche as it reentered the antibiotics field; it has since sealed partnerships with Meiji Seika Pharma, Discuva, and Spero Therapeutics.
This article has been sent to the following recipient: